Evidence map›Paper›PMID 41084611›Full record

ArticleTherapeutic advances in drug safety2025

Impact of social determinants of health on safety of patients in device clinical trials conducted at a safety-net hospital.

Anna C Schneider, Katherine N Cilley, Marina A Malikova

Abstract read
In one paragraph

Article in Therapeutic advances in drug safety, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Anna C SchneiderDepartment of Surgery, Chobanian and Avedisian School of Medicine, Boston Medical Center, Boston University, Boston, MA, USA.
Katherine N CilleyDepartment of Surgery, Chobanian and Avedisian School of Medicine, Boston Medical Center, Boston University, Boston, MA, USA.
Marina A MalikovaDepartment of Surgery, Chobanian and Avedisian School of Medicine, Boston Medical Center, Boston University, 85 East Concord Street, Boston, MA 02118, USA.ORCID https://orcid.org/0000-0003-1370-187X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Underrepresentation of various populations in clinical trials limits our understanding of efficacy and safety outcomes, as individuals with diverse backgrounds can respond differently to the same interventions. Inclusion of diverse groups in device clinical trials is essential for providing innovative, patient-centric solutions and achieving health equity. Objective: To evaluate how social determinants correlate with safety events in clinical trials with medical devices to identify safety signals, improve safety profiles, and develop risk-based safety and quality management strategies. Design: A single-center, retrospective study was conducted for clinical trials with medical devices at a safety-net hospital. Methods: Data obtained from 223 patients randomized into 19 device clinical trials were assessed retrospectively for correlation of social determinants of health variables and study protocol complexity with study protocol deviations, adverse events, and study dropout rates by using the Kruskal-Wallis and Spearman correlation tests. Results: Lower median income was associated with an increased number of adverse events ( Conclusion: Examining the root causes of these outcomes, as well as patient-centric medical management, can improve data integrity and aid risk-based safety and quality management in device clinical trials.

Indexed as

medical devicesrisk and safety managementsafety reportingsocial determinants of healthsurgical clinical trials

Identifiers

PMID41084611
PMCPMC12515286

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.